PMID: 10975770Sep 7, 2000Paper

Is it time to adopt proton pump inhibitors in the prevention of non-steroidal anti-inflammatory drug gastropathy?

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
S A Malki, N D Yeomans

Abstract

No abstract listed.

References

Non-steroid anti-inflammatory drug associated ulcer: epidemiology, causation and treatment

Sep 1, 1991·Journal of Gastroenterology and Hepatology·M J LangmanN Yeomans

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.

Mar 1, 1989·Digestive Diseases and Sciences·M G RobinsonC W Warner

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

Oct 22, 1988·BMJ : British Medical Journal·R S EhsanullahJ R Wood

Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation

Oct 1, 1987·Archives of Internal Medicine·S H RothR J Hartman

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

Aug 15, 1995·Annals of Internal Medicine·F E SilversteinG S Geis

Efficacy of 12 months' misoprostol as prophylaxis against NSAID-induced gastric ulcers. A placebo-controlled trial

Jan 1, 1994·Scandinavian Journal of Rheumatology·S L ElliottR A Smallwood

Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group

Aug 15, 1993·Annals of Internal Medicine·D Y GrahamL S Teoh

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

May 30, 1996·The New England Journal of Medicine·A S TahaR I Russell

NSAID gastropathy. A new understanding

Aug 12, 1996·Archives of Internal Medicine·S H Roth

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

Aug 1, 1996·Scandinavian Journal of Gastroenterology·P EkströmP Unge

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

Mar 12, 1998·The New England Journal of Medicine·N D YeomansC J Hawkey

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group

Mar 12, 1998·The New England Journal of Medicine·C J HawkeyN D Yeomans

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

Aug 6, 1998·Alimentary Pharmacology & Therapeutics·D CullenC J Hawkey

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

Sep 29, 1998·Arthritis and Rheumatism·L S SimonG S Geis

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

Dec 28, 1999·Lancet·P EmeryG S Geis

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group

Feb 29, 2000·Arthritis and Rheumatism·C HawkeyE Mortensen

Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study

Sep 7, 2000·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G Bianchi PorroT Santagada

❮ Previous
Next ❯

Citations

The protective effect of eupatilin on indomethacin-induced cell damage in cultured feline ileal smooth muscle cells: involvement of HO-1 and ERK

Apr 29, 2008·Journal of Ethnopharmacology·Hyun Ju SongUy Dong Sohn

Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling

Jul 24, 2007·The Journal of Surgical Research·Maria J RedlakThomas A Miller

Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis

Feb 6, 2010·Biochemical Pharmacology·Tomoaki IshiharaTohru Mizushima

Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa

May 13, 2009·Cancer Science·Tomomitsu TaharaTomiyasu Arisawa

COX-1 and COX-2 inhibitors

Sep 22, 2001·Best Practice & Research. Clinical Gastroenterology·C J Hawkey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved